BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients

OBJECTIVES: We aimed to assess the safety and performance of the Magmaris sirolimus‐eluting bioresorbable magnesium scaffold in a large patient population. BACKGROUND: Magmaris has shown good outcomes in small‐sized controlled trials, but further data are needed to confirm its usability, safety, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Verheye, Stefan, Wlodarczak, Adrian, Montorsi, Piero, Torzewski, Jan, Bennett, Johan, Haude, Michael, Starmer, Gregory, Buck, Thomas, Wiemer, Marcus, Nuruddin, Amin A. B., Yan, Bryan P.‐Y., Lee, Michael K.‐Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359313/
https://www.ncbi.nlm.nih.gov/pubmed/32881396
http://dx.doi.org/10.1002/ccd.29260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359313/
https://www.ncbi.nlm.nih.gov/pubmed/32881396
http://dx.doi.org/10.1002/ccd.29260

Ejemplares similares